Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-25-008772

Chief Medical Officer gave up 7,990 shares (to pay taxes)

  • Chief Medical Officer acquired 1,905 shares (grant or award)
  • Chief Medical Officer acquired 23,216 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Matthew Scott Chief Medical Officer 2025-01-30 Option exercise +9,275 74,000 D: show line 1 in the form
Harris Matthew Scott Chief Medical Officer 2025-01-30 Shares withheld for taxes −3,173 $7.00 $22,211 70,827 D: show line 2 in the form
Harris Matthew Scott Chief Medical Officer 2025-01-31 Grant or award +1,905 $5.18 $9,868 72,732 D: show line 3 in the form
Harris Matthew Scott Chief Medical Officer 2025-02-01 Option exercise +6,166 78,898 D: show line 4 in the form
Harris Matthew Scott Chief Medical Officer 2025-02-01 Shares withheld for taxes −2,109 $6.64 $14,004 76,789 D: show line 5 in the form
Harris Matthew Scott Chief Medical Officer 2025-02-02 Option exercise +7,775 84,564 D: show line 6 in the form
Harris Matthew Scott Chief Medical Officer 2025-02-02 Shares withheld for taxes −2,708 $6.64 $17,981 81,856 D: show line 7 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Harris Matthew Scott Chief Medical Officer 2025-01-30 Option exercise · Restricted Stock Units +9,275 18,550 D: show line 8 in the form
Harris Matthew Scott Chief Medical Officer 2025-02-01 Option exercise · Restricted Stock Units +6,166 0 D: show line 9 in the form
Harris Matthew Scott Chief Medical Officer 2025-02-02 Option exercise · Restricted Stock Units +7,775 7,775 D: show line 10 in the form
Loading xslF345X05/tm255357-3_4seq1.xml…